Prof. Jeffrey Tobias – Radiation advantages & drawbacks of the TARGIT-A long-term outcomes

Share this video


Prof. Jeffrey Tobias

Professor of Oncology at the University College London (UK) and joint initiator of the TARGIT-A study


Summary

Joint initiator talking about the radiation advantages & drawbacks of the TARGIT-A long-term outcomes

In this recorded clinical webinar Prof. Jeffrey Tobias is presenting the recently published 8.6 years results of the TARGIT-A study on breast cancer from his perspective as joint initiator of the TARGIT-A study and Professor of Oncology. His talk will focus on radiation advantages and drawbacks of the TARGIT-A long-term outcomes, followed by a panel discussion together with Prof. Jayant Vaidya and Prof. Max Bulsara.


To view, please login or register. MyZEISS is your gateway to all digital offerings from ZEISS.

  • Gain full access to clinical insights from peers. 
  • Access latest training and learning content for you and your team.
  • Get quick access to tools and documents. 


Share this video


Related articles